Sol-Gel Technologies (SLGL) Non-Current Assets (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Non-Current Assets came in at $2.8 million in Q1 2026, down 23.96% year-on-year from $3.6 million in Q1 2025, and down 6.28% on a QoQ basis from $2.9 million in Q4 2025.

Sol-Gel Technologies (SLGL) Non-Current Assets (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Non-Current Assets data on file, last reported at $2.8 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 23.96% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 23.96% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 35.27% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $2.8 million, down from $2.9 million in the prior quarter.
  • Over the last five years, Non-Current Assets for SLGL reached as high as $9.3 million in Q1 2022 and fell as low as $2.8 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $4.5 million across 5 years, with a median of $3.7 million in 2022.
  • On a YoY basis, Non-Current Assets climbed as much as 75.06% in 2022 and fell as far as 70.43% in 2022.
  • Year by year, Non-Current Assets stood at $3.6 million in 2022, then increased by 15.31% to $4.1 million in 2023, then rose by 10.46% to $4.6 million in 2024, then sank by 35.27% to $2.9 million in 2025, then decreased by 6.28% to $2.8 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $2.8 million in Q1 2026, $2.9 million in Q4 2025, and $2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - 2.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.76 Mn
Dec 31, 2025 2.95 Mn
Sep 30, 2025 2.94 Mn
Jun 30, 2025 3.05 Mn
Mar 31, 2025 3.63 Mn
Dec 31, 2024 4.55 Mn
Sep 30, 2024 5.03 Mn
Jun 30, 2024 3.72 Mn
Mar 31, 2024 3.90 Mn
Dec 31, 2023 4.12 Mn
Sep 30, 2023 4.39 Mn
Jun 30, 2023 3.51 Mn
Mar 31, 2023 8.36 Mn
Dec 31, 2022 3.57 Mn
Sep 30, 2022 3.73 Mn
Jun 30, 2022 6.51 Mn
Mar 31, 2022 9.34 Mn
Dec 31, 2021 12.08 Mn
Sep 30, 2021 4.68 Mn
Jun 30, 2021 5.01 Mn